Publication | Closed Access

Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease

Alzheimer's DiseaseMedicineDementiaPsychopharmacologyNeuropharmacologyNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationPharmacologyNeurochemistrySocial SciencesLewy Body Dementia